Zaderej Karen L. Insider Trades

Insider Trading History

Track insider trading activity for Zaderej Karen L.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $521k 40,000 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$699k 40,000 shares
$17.48
$13.03
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $502k 38,500 shares
Last Trade
Jul 11, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$20.7k 2,000 shares
$10.36
$13.03
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $0 0 shares
Last Trade
Jul 11, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$20.7k 2,000 shares
$10.36
$13.03
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $476k 36,500 shares
Last Trade
May 19, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$30k 5,000 shares
$5.99
$13.03
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $410k 31,500 shares
Last Trade
May 16, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$29.1k 5,000 shares
$5.81
$13.03
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $345k 26,500 shares
Last Trade
May 15, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$27.4k 5,000 shares
$5.47
$13.03
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $280k 21,500 shares
Last Trade
May 14, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$27.1k 5,000 shares
$5.42
$13.03
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $521k 40,000 shares
Last Trade
Jan 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$330k 40,000 shares
$8.26
$13.03
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $215k 16,500 shares
Last Trade
Aug 19, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$99.8k 12,500 shares
$7.98
$13.03
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $52.1k 4,000 shares
Last Trade
Jul 11, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.8k 2,000 shares
$9.91
$13.03
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $26.1k 2,000 shares
Last Trade
Jul 11, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.8k 2,000 shares
$9.91
$13.03
Axogen
Axogen AXGN
CEO
Holding Value $49.2M 1,143,788 shares
Last Trade
Mar 21, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$302k 39,280 shares
$7.68
$43.00
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $326k 25,014 shares
Last Trade
Jan 05, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$510k 25,014 shares
$20.40
$13.03
Axogen
Axogen AXGN
CEO
Holding Value $46.1M 1,072,746 shares
Last Trade
Jul 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$198k 22,076 shares
$8.95
$43.00
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $52.1k 4,000 shares
Last Trade
Jul 11, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.4k 2,000 shares
$9.20
$13.03
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $26.1k 2,000 shares
Last Trade
Jul 11, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$18.4k 2,000 shares
$9.20
$13.03
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals EYPT
Director
Holding Value $340k 26,100 shares
Last Trade
Jun 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$270k 39,100 shares
$6.90
$13.03
Axogen
Axogen AXGN
CEO
Holding Value $45.2M 1,050,670 shares
Last Trade
Mar 16, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$314k 37,975 shares
$8.27
$43.00
Axogen
Axogen AXGN
CEO
Holding Value $1.08M 25,000 shares
Last Trade
Mar 16, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$314k 37,975 shares
$8.27
$43.00
Axogen
Axogen AXGN
CEO
Holding Value $7.7M 179,000 shares
Last Trade
Mar 16, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.41M 291,000 shares
$8.27
$43.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up